Efficacy of Finasteride for Treating Patients with Androgenetic Alopecia who are Pileous in other Areas: A Pilot Study in Japan

被引:5
|
作者
Inadomi, Toru [1 ]
机构
[1] Ichikawa Rio Dermatol Clin, 3-1-20-1F Ichikawa Minami, Chiba 2720033, Japan
关键词
Androgenetic alopecia; finasteride; pilous;
D O I
10.4103/0019-5154.127677
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Androgenetic alopecia (AGA) involves androgen-dependent hair loss and finasteride is an established treatment for the disease. However, reports of the influence of finasteride on hair growth in other areas of the body are lacking. Aims: To investigate the effects of finasteride on hair, including the head and other areas of the body. Materials and Methods: Based on whether AGA patients felt they were pileous in areas other than the head, they were divided into Group A (pileous) or Group B (not pileous). Finasteride (1 mg/day) was prescribed for both groups for at least 6 months, after which patients were asked to estimate the medicine's effects and any changes of their hair growth. Results and Conclusions: A total of 18 out of 37 patients were placed in Group A and 19 of them were in Group B, suggesting that about half of AGA patients in Japan are pileous in other parts of the body. Oral finasteride was effective (excellent or good) in 22 out of 37 (59.5%) patients overall, in 16 out of 18 (88.9%) patients in Group A, and in 6 out of 19 (31.6%) patients in Group B. None of the patients reported that oral finasteride had any effect on their hair growth other than on their head. Finasteride is more effective for treating AGA patients who are pileous in other areas of the body.
引用
收藏
页码:163 / 165
页数:3
相关论文
共 50 条
  • [31] Open non-comparative multicenter pilot study on the efficacy and tolerance of sertraline in the treatment of patients with major depression who cannot tolerate tricyclic antidepressants
    Filip, V.
    Seifertova, D.
    Ceskova, E.
    Svestka, J.
    Korinkova, V.
    Klaschka, J.
    BEHAVIOURAL PHARMACOLOGY, 1995, 6 : 31 - 31
  • [32] The efficacy and safety of lenvatinib in patients who did not meet the inclusion criteria of the phase 3 trial (REFLECT trial) in real-world practice in Japan: A nationwide multicenter study in Japan.
    Tsuchiya, Kaoru
    Kurosaki, Masayuki
    Marusawa, Hiroyuki
    Abe, Takehiko
    Ogawa, Chikara
    Sohda, Tetsuro
    Kimura, Hiroyuki
    Kondo, Masahiko
    Tsuji, Keiji
    Furuta, Koichiro
    Shigeno, Masaya
    Joko, Kouji
    Narita, Ryoichi
    Uchida, Yasushi
    Yoshida, Hideo
    Akahane, Takehiro
    Kobashi, Haruhiko
    Mitsuda, Akeri
    Kojima, Yuji
    Izumi, Namiki
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [33] A pilot study to test the efficacy of a combination of gleevec with thalidomide in patients with idiopathic primary myelofibrosis, myelofibrosis with myeloid metaplasia and myelodysplastic syndromes who present with myelofibrosis.
    Batus, Marta
    Shammo, Jamile M.
    Venugopal, Parameswaran
    Gregory, Stephanie A.
    Raza, Azra
    BLOOD, 2006, 108 (11) : 295B - 295B
  • [34] Efficacy of photo-thermal-bioactivated platelet-rich plasma for skin biostimulation in patients not eligible for other medical-aesthetic treatment: A pilot study
    Sanz, Carlota Hernandez
    Pinto, Hernan
    SKIN RESEARCH AND TECHNOLOGY, 2023, 29 (07)
  • [35] Safety and efficacy of luspatercept in treating anemia associated with myelodysplastic syndrome with ring sideroblasts in Asian patients who require red blood cell transfusions: a phase II bridging study
    Chang, Chunkang
    Suzuki, Takahiro
    Liang, Yang
    Tong, Hongyan
    Usuki, Kensuke
    Liu, Qifa
    Wu, Yu
    Fujisaki, Tomoaki
    Han, Bing
    Huang, Ruibin
    Morita, Yasuyoshi
    Miao, Miao
    Nakashima, Yasuhiro
    Tian, Yu
    Pu, Jie
    Aggarwal, Dimple
    Pozharskaya, Veronika
    Shi, Wenhui
    Xiao, Zhijian
    Mitani, Kinuko
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2025, 16
  • [36] Efficacy of extracting and preventively intervening late-stage older adults who are at high risk for spending high medical costs by using the health check-up system in Japan: a pilot study
    Kazawa, Kana
    Kawai, Madoka
    Moriyama, Michiko
    FRONTIERS IN PUBLIC HEALTH, 2024, 12
  • [37] Efficacy of Multi Matrix System mesalazine for the induction of remission in patients with ulcerative colitis who insufficiently respond to other mesalazine formulations: A Japanese single-center study
    Sugiyama, Kohei
    Tanaka, Hiroki
    Miyakawa, Maki
    Nasuno, Masanao
    Motoya, Satoshi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 110 - 110
  • [38] Long-term safety and efficacy of antimuscarinic add-on therapy in patients with overactive bladder who had a suboptimal response to mirabegron monotherapy: A multicenter, randomized study in Japan (MILAI II study)
    Yamaguchi, Osamu
    Kakizaki, Hidehiro
    Homma, Yukio
    Igawa, Yasuhiko
    Takeda, Masayuki
    Nishizawa, Osamu
    Gotoh, Momokazu
    Yoshida, Masaki
    Yokoyama, Osamu
    Seki, Narihito
    Okitsu, Akira
    Hamada, Takuya
    Kobayashi, Akiko
    Kuroishi, Kentaro
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 (03) : 342 - 352
  • [39] Long-term efficacy and tolerability of quetiapine in patients with schizophrenia who switched from other antipsychotics because of inadequate therapeutic response—a prospective open-label study
    Naoki Hashimoto
    Atsuhito Toyomaki
    Minoru Honda
    Satoru Miyano
    Nobuyuki Nitta
    Hiroyuki Sawayama
    Yasufumi Sugawara
    Keiichi Uemura
    Noriko Tsukamoto
    Tsukasa Koyama
    Ichiro Kusumi
    Annals of General Psychiatry, 14
  • [40] An Efficacy and Safety Study of Remogliflozin in Obese Indian Type 2 Diabetes Mellitus Patients Who Were Inadequately Controlled on Insulin Glargine Plus other Oral Hypoglycemic Agents
    Shankar, Anand
    CURRENT DIABETES REVIEWS, 2021, 17 (07)